Stay updated on IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page.

Latest updates to the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page
- Check6 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4. No changes to study content or outcomes.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded Melanoma as a related topic and MedlinePlus Genetics as related topics on the page to provide additional context and resources. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check27 days agoChange DetectedFooter updates include Revision: v3.3.3 and removal of certain non-core footer items (HHS Vulnerability Disclosure, Melanoma, MedlinePlus Genetics, related topics, and Revision: v3.3.2). This change does not modify trial details or access to the study information; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check35 days agoChange Detected- The page now shows a new Melanoma topic tag and a MedlinePlus Genetics related topics link, which are minor metadata/navigation updates that do not affect core study data. - To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page's revision indicator was updated from v3.2.0 to v3.3.2, reflecting a minor version change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedRemoved non-core items: government funding status notice and topic links (Melanoma; MedlinePlus Genetics). This does not affect study details; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page.